Drug Approvals
🇺🇸 FDA Page 30FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 349–360 of 665 articles
Eli Lilly's $200M Fraud Allegations: Implications for Pharma
RFK Jr.’s Screen Time Warning: Implications for Pharma
RA Capital Secures $75M for Biotech SPAC: Implications for Pharma
Guarding Biotech from China: Big Bets in Longevity
How Florida Hospitals Secured Medicaid Funds: A Strategic Overview
BioMarin Seeks Approval for Voxzogo in Short Stature Indication
China's Drugmakers Shine at ASCO26: Key Insights
Senate Committee Questions NIH Director on 2027 Budget: Key Insights
NIH Infectious Disease Institute Leadership Change: Implications for Pharma
Big Pharma Q1 Growth Insights: Lilly, AbbVie, J&J, AZ Lead the Charge
BMS Expands in Texas While Novartis Faces Tenant Challenges
Gilead's Commitment to Combat Visceral Leishmaniasis with AmBiosome